BIA 28-6156

Advertisement

cGxPJobs Banner

Bial Discontinues Pariceract After Phase 2b ACTIVATE Trial Miss

PORTO, Portugal, June 9, 2026 Bial announced topline results from its Phase 2b ACTIVATE study evaluating BIA 28-6156 (pariceract)...

By cGxPwire Editor
June 10, 2026

Read More

Advertisement

cGxPJobs

Directory